About Us
Services & Solutions
Peptide Chemistry Medicinal Chemistry Parallel Synthesis Computational Chemistry Synthetic Chemistry Analytical Chemistry Scale Up Chemistry Fragment Based Drug Discovery (FBDD) Integrated Drug Discovery
In Vivo PK and TK In Vitro ADME Bioanalytical Service Toxicity In Rodents, Dogs and Monkeys Large Molecule Development and Bioanalysis Integrated Drug Discovery
Discovery Biology Oncology Pharmacology Integrated Drug Discovery
Assay Development Assay Platform Technologies Biochemical Assays Cellular Assays Ligand Binding Assays Protein Science Surface Plasmon Resonance (SPR) Biologics
PDX CDX Orthotopic Models Syngeneic Models Humanized Mouse Models CAR-T and CAR-NK Mouse Models ELISA Assays In Vitro Assays
Immunology & Inflammation Metabolic MASH Mouse Models Respiratory Neuroscience Safety Pharmacology
Process R&D Scale Up Synthesis Drug Substance Manufacturing IND Enabling
Flow Chemistry Sugar Chemistry Peptide Chemistry Preparative Purification Capacity Process Safety Assessment
Synthetic and Scale Up Chemistry
Kilo and Pilot Scale API RSM and Intermediates QA & EHS
Preformulation Formulation Development Drug Product Manufacturing IND Enabling
Hot Melt Extrusion (HME) Spray Dried Dispersion (SDD) Amorphous Solid Dispersion Bioavailability Enhancement Modified Release
Platforms
News & Resources
Careers
Contact Us
×

webinars

Company News Events Insights Webinars Virtual Tours Our Stories
UPCOMING WEBINAR

Accelerating PROTACs and RIPTACs Programs: From Synthesis to In Vitro Profiling

Want to speed up early discovery of PROTACs and RIPTACs? These heterobifunctional molecules move beyond classical occupancy-driven inhibition to event-driven modulation of protein function, enabling therapeutic targeting of proteins that were previously considered undruggable. This webinar demonstrates how chemical synthesis and in vitro profiling can be combined to rapidly generate, optimize, and advance these molecules in early discovery programs.
Register Now
PAST WEBINARS

Expanding Peptide Drug Discovery with Next-Generation Peptide DELs

Peptide therapeutics offer highly specific and versatile treatments for complex and previously undruggable targets. High-throughput peptide library screening has accelerated discovery. However, traditional platforms such as phage or mRNA display are inherently limited by biological translation processes. DNA-encoded library (DEL) technology provides an alternative, enabling incorporation of unnatural amino acids and diverse cyclization strategies, and producing peptides with improved stability and prolonged retention.
Watch Now
PAST WEBINARS

Metabolic Instability of Peptide Therapeutics: Mechanisms, Analytical Strategies, and Design Solutions for Clinical Success

Metabolic instability is a key challenge in developing peptide therapeutics, and factors like rapid clearance and complex, multi-pathway biotransformation can further limit their effectiveness. Understanding and addressing these hurdles can unlock the full potential of peptide drugs, enabling them to reach challenging biological targets, support rational chemical design, and achieve clinical success. This webinar presents an integrated mechanism–analytics–design perspective to tackle these challenges and accelerate peptide drug discovery.
Watch Now
PAST WEBINARS

Accelerating Clinical Entry for Poorly Soluble Molecules: A Proven and Structured Roadmap

Poorly soluble molecules face unique challenges that can slow development and limit clinical success. Early formulation decisions are critical for determining bioavailability, in vivo exposure and the speed to IND submission and first-in-human studies. This webinar will show how tailored early-phase strategies, aligned with molecule properties and clinical stage, can overcome solubility, bioavailability limitations and related formulation challenges.
Watch Now
PAST WEBINARS

High Translatable DIO Rodent Model: Accelerating Weight Loss Drug Discovery

Obesity remains a critical global health threat, affecting over one billion people worldwide and exacerbating risks for type 2 diabetes, cardiovascular diseases, and fatty liver disease. The pharmaceutical landscape is witnessing rapid transformation through novel oral GLP-1 agents, long-acting injectables, and multi-target therapies that are redefining treatment possibilities.
Watch Now
PAST WEBINARS

ADME and Bioanalytical Strategies for ADCs: Challenges, Emerging Technologies, and Regulatory Considerations

Antibody-drug conjugates (ADCs) are transforming cancer treatment, but their development brings unique challenges in the DMPK field, including ADME, bioanalysis, and regulatory registration. This webinar explores integrated DMPK and bioanalytical strategies for ADC discovery and development, grounded in recent analytical advances, global guidelines, and real-world experience.
Watch Now
Total 20 1234
Subscribe to BioDuro
Receive our newsletter and information on upcoming events
Your trusted partner from drug discovery and
development to commercialization
Services & Solutions

Chemistry

DMPK

Biology

Drug Substance

Drug Product

Platforms

Antibody-Drug Conjugate

Peptide

Compound Management

PROTAC

Solution Engine

Integrated Drug Discovery

IND Enabling

DNA-Encoded Library

MASH Mouse Models

About Us

News & Resources

Careers

Contact Us

© 2025 BioDuro. All rights reserved
Terms of Use Privacy Policy
✉️Contact Us
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all